Levalbuterol tartrate
CAS: 661464-94-4
Ref. 3D-LBB46494
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued | ||
100mg | Discontinued |
Product Information
- 1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, (alpha1R)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt)
- 1,3-Benzenedimethanol, α<sup>1</sup>-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, (α<sup>1</sup>R)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt)
- Levalbuterol tartrate [USP]
- Levosalbutamol tartrate
- Unii-Ads4I3E22M
- Xopenex HFA
Levalbuterol tartrate is a medication that belongs to the group of bronchodilators. It is used to prevent and treat wheezing, shortness of breath, chest tightness, and coughing. Levalbuterol tartrate has a side-effect profile that is similar to other bronchodilators. This drug can lead to abnormal liver function, which may be due to its ability to inhibit hmg-coa reductase and acetylcholine, among other effects. Levalbuterol tartrate also has a long duration of action, which may be due to its polymorphic chemical structure.